Xenetic Biosciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.11

-0.07 (-2.20%)

As of May 16, 2:34 AM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,074.6% upside

Low Target $23.38

Average Target $36.53

High Target $47.42

Current Price $3.11

Current
$3.11

Target
$36.53

$23.38 $36.53 avg $47.42

Scenario Analysis

Bear Case

$23.38

651.8%

Low target

Base Case

$36.53

+1,074.6%

Avg target

Bull Case

$47.42

+1,424.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$13.93

-77.7% from high

52-Week Low

$1.90

+63.7% from low

Target vs 52W High

$36.53

+162.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%